Aptar Q2 FY26 EPS drops 19% to $1.36; net sales rise 6% to $1.03 billion - ATR News | RalliesAptar Q2 FY26 EPS drops 19% to $1.36; net sales rise 6% to $1.03 billion
A
ATR• Outlook and shareholder returns
- The company forecast Q3 adjusted EPS of $1.45-$1.53.
- Aptar returned $81 million to shareholders via buybacks and dividends.
Segment performance and margin pressure
- Pharma net sales climbed 4%, Beauty rose 10%, and Closures increased 7%; all three segments posted lower adjusted EBITDA margins.
- Management said emergency medicine destocking weighed on Pharma; it expects the headwind to abate by Q4.
AptarGroup reports lower quarterly earnings as sales rise
- AptarGroup Q2 net income fell to $88 million; diluted EPS dropped to $1.36 as net sales rose 6% to $1.03 billion.
- Adjusted EBITDA margin narrowed to 20.7% from 22.6%; adjusted diluted EPS declined to $1.42.
